360 High-Risk Vulnerability Immunization Tool V2.0 vs IKARUS anti.virus Home: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

IKARUS anti.virus Home: Antivirus software protecting up to 3 Windows PCs from malware. built by IKARUS Security Software. Core capabilities include Real-time scanning of downloads, Read and write access monitoring, Automatic threat isolation and blocking of malicious files..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. IKARUS anti.virus Home differentiates with Real-time scanning of downloads, Read and write access monitoring, Automatic threat isolation and blocking of malicious files.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). IKARUS anti.virus Home is developed by IKARUS Security Software. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and IKARUS anti.virus Home serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Windows Security. Review the feature comparison above to determine which fits your requirements.